Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 16 for Clinical Trial
  1. ... over time) unless they are participating in a clinical trial (research study to see whether a medication may ...
  2. ... by the SARS-CoV-2 virus.Information from clinical trials is available at this time to support the ... COVID-19 vaccine to prevent COVID-19. In clinical trials, approximately 21,895 individuals 18 years of age ...
  3. ... by the SARS-CoV-2 virus.Information from clinical trials is available at this time to support the ... the COVID-19 vaccine, adjuvanted?In an ongoing clinical trial, theCOVID-19 vaccine, adjuvanted has been shown to ...
  4. ... alerting patients and health care professionals that a clinical trial (OCEAN, Study OP-103) evaluating Pepaxto (melphalan flufenamide) ... has also suspended enrollment in other ongoing Pepaxto clinical trials. Patients receiving clinical benefit from Pepaxto may continue ...
  5. ... The FDA is warning that results from a clinical trial show a possible increased risk of death with ... public meeting to discuss the findings from the clinical trial and whether Copiktra should continue to be prescribed ...
  6. ... 19) caused by the SARS-CoV-2 virus.Clinical trial information is available at this time to support the use of bebtelovimab for the treatment of COVID-19. More information is ... to your doctor about the risks and benefits of receiving this medication.
  7. ... by the SARS-CoV-2 virus.Only limited clinical trial information is available at this time to support the use of tixagevimab and cilgavimab injection for the prevention of ... to receive tixagevimab and cilgavimab injection for prevention of COVID-19.
  8. ... by the SARS-CoV-2 virus.Only limited clinical trial information is available at this time to support the use of bamlanivimab for the treatment of COVID-19. More information is ... to your doctor about the risks and benefits of receiving this medication.
  9. ... 19) caused by the SARS-CoV-2 virus.Clinical trial information is available at this time to support the use of sotrovimab for the treatment of COVID-19. More information is needed ... variant susceptibility to this drug and regional variant frequency.
  10. ... by the SARS-CoV-2 virus.Only limited clinical trial information is available at this time to support the use of molnupiravir for the treatment of COVID-19. More information is ... to allow certain adults to receive molnupiravir for treatment of COVID-19.
previous · 1 · 2 · next